KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,535,747 | +2.3% | 616,169 | +3.8% | 0.48% | +10.3% |
| Q4 2022 | $7,366,092 | -3.3% | 593,561 | +9.1% | 0.44% | -1.8% |
| Q4 2021 | $7,618,000 | -46.1% | 544,173 | -27.9% | 0.44% | -46.9% |
| Q3 2021 | $14,143,000 | +52.6% | 755,121 | +69.9% | 0.84% | +56.9% |
| Q2 2021 | $9,265,000 | +294.1% | 444,372 | +434.3% | 0.53% | +278.7% |
| Q1 2021 | $2,351,000 | -40.3% | 83,164 | -31.1% | 0.14% | -40.0% |
| Q4 2020 | $3,941,000 | -42.9% | 120,677 | -46.4% | 0.24% | -54.1% |
| Q3 2020 | $6,902,000 | -30.7% | 225,259 | -63.1% | 0.51% | -18.5% |
| Q2 2020 | $9,959,000 | +130.1% | 610,979 | +147.0% | 0.63% | +62.7% |
| Q3 2018 | $4,329,000 | +28.4% | 247,385 | +33.6% | 0.39% | +79.5% |
| Q2 2018 | $3,371,000 | – | 185,195 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |